Professional perspective
Clinical relevance
- Differential diagnosis of gingivitis versus periodontitis based on periodontitis-related attachment and bone loss
- Baseline and follow-up recording of bleeding on probing (BOP) for monitoring over time
- Identifying modifying factors (pregnancy, medications, smoking)
- Classification in a reduced periodontium: non-periodontitis-related versus treated periodontitis
- Patient motivation and individualized oral hygiene instruction
Diagnosis and current classification
The current case definition for gingivitis comes from the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions (EFP/AAP). A gingivitis case (GC) is present in an intact periodontium when bleeding on probing (BOP) occurs at 10 percent or more of examined sites, with probing depths of 3 millimeters or less and no clinical attachment loss or radiographic bone loss. Extent is classified as localized (BOP 10 to 30 percent) or generalized (BOP over 30 percent).
The BOP-based gingivitis definition applies directly to an intact periodontium and can also be applied to a reduced periodontium without a history of periodontitis, for example with gingival recession or after surgical crown lengthening. Patients with successfully treated periodontitis, by contrast, retain their periodontitis diagnosis and are assessed for stability or remission, even when clinically unremarkable. A BOP value below 10 percent, without attachment or bone loss, is considered periodontally healthy.
Clinical implications
The decisive diagnostic distinction from periodontitis is demonstrable periodontitis-related attachment loss. A periodontitis case is defined as interdental clinical attachment loss detectable at two or more non-adjacent teeth, or buccal or oral attachment loss of at least 3 millimeters with probing depths over 3 millimeters at two or more teeth, in each case after excluding non-periodontitis causes of attachment loss. This is a diagnostic criterion rather than necessarily the biological moment of transition. Without such evidence, the diagnosis remains gingivitis, regardless of how pronounced the visible inflammation appears.
Modifying factors
Beyond dental biofilm as the primary etiologic factor, systemic and local factors can modify how gingivitis presents: hormonal changes (pregnancy, puberty, hormonal contraception) and certain medications, including some calcium channel blockers, anticonvulsants, and cyclosporine, which can promote gingival enlargement. These factors can complicate biofilm control and intensify plaque-induced inflammation.
Smoking occupies a distinct position. It can clinically dampen bleeding and redness, masking the true extent of inflammation, while simultaneously affecting immune response and tissue healing. It ranks among the most significant risk factors for progression to periodontitis.
Guidelines
The German S3 clinical guideline on home mechanical biofilm management in the prevention and treatment of gingivitis (AWMF 083-022, DG PARO / DGZMK) was last updated on 12 November 2018, with a revised long and short version on 9 February 2021 (amendment), valid until 11 November 2023. An update is in progress. The underlying case definitions, however, rest on the 2017 World Workshop consensus, which remains current internationally.
Evidence summary
What current evidence supports
- Gingivitis is internationally defined by bleeding on probing at 10 percent or more of sites, probing depths of 3 millimeters or less, and no periodontitis-related attachment or bone loss
- Effective biofilm control typically produces visible improvement within days to a few weeks
- Smoking can mask clinical signs of gingivitis while independently increasing periodontitis risk
- Reported prevalence varies widely, from roughly 20 percent to over 90 percent depending on diagnostic criteria, age group, and population studied
Why this matters
Because gingivitis remains reversible when biofilm control improves, most gum inflammation can resolve without professional periodontal treatment. Recognizing the distinction from periodontitis early keeps care proportionate to what the tissue actually needs, neither overtreating a reversible condition nor underestimating early warning signs.
What remains uncertain
- Why reported gingivitis prevalence varies so widely across populations and studies, beyond differences in diagnostic criteria alone
- The precise individual timeline and threshold at which sustained gingivitis increases periodontitis risk
- How reliably clinical signs alone predict outcomes in smokers, given that smoking can mask the visible extent of inflammation
Trombelli, Farina, Silva, Tatakis (2018): Plaque-induced gingivitis: Case definition and diagnostic considerations. Journal of Clinical Periodontology, 45(Suppl 20), S44-S67. Consensus report from the 2017 World Workshop working group; establishes the current case definition and BOP-based diagnostic criteria. A classification and consensus document rather than an intervention review.
Chapple, Mealey, Van Dyke, et al. (2018): Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium. Journal of Clinical Periodontology, 45(Suppl 20), S68-S77. Defines the states of periodontal health: intact periodontium, reduced periodontium without a history of periodontitis, and the stable or remission periodontitis patient.
Papapanou, Sanz, Buduneli, et al. (2018): Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop. Journal of Clinical Periodontology, 45(Suppl 20), S162-S170. Defines the diagnostic criteria for periodontitis, marking the boundary with gingivitis.